Literature DB >> 16965448

The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome.

M E Lacouture, S E Lai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16965448     DOI： 10.1111/j.1365-2133.2006.07452.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  24 in total

1.  Transgenic expression of human amphiregulin in mouse skin: inflammatory epidermal hyperplasia and enlarged sebaceous glands.

Authors:  Yong Li; Stefan W Stoll; Sahil Sekhon; Caroline Talsma; Maya I Camhi; Jennifer L Jones; Sylviane Lambert; Hue Marley; Laure Rittié; Marina Grachtchouk; Yi Fritz; Nicole L Ward; James T Elder
Journal:  Exp Dermatol       Date:  2016-01-12       Impact factor: 3.960

2.  Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions.

Authors:  Iris Amitay-Laish; Michael David; Salomon M Stemmer
Journal:  Oncologist       Date:  2010-08-13

Review 3.  Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors.

Authors:  Emmanuelle Vigarios; Joel B Epstein; Vincent Sibaud
Journal:  Support Care Cancer       Date:  2017-02-22       Impact factor: 3.603

4.  Rash rates with egfr inhibitors: meta-analysis.

Authors:  N Mittmann; S J Seung
Journal:  Curr Oncol       Date:  2011-04       Impact factor: 3.677

5.  Lack of Cetuximab induced skin toxicity in a previously irradiated field: case report and review of the literature.

Authors:  Madhava R Kanakamedala; Satyaseelan Packianathan; Srinivasan Vijayakumar
Journal:  Radiat Oncol       Date:  2010-05-17       Impact factor: 3.481

6.  Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature.

Authors:  Anna Ferrazzi; Irene Russo; Giulia Pasello; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2015-11-19       Impact factor: 2.447

7.  Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.

Authors:  P Forde; C Murphy; C O'Sullivan; D Carney
Journal:  Ir J Med Sci       Date:  2010-01-28       Impact factor: 1.568

8.  Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management.

Authors:  Shaad E Abdullah; Missak Haigentz; Bilal Piperdi
Journal:  Chemother Res Pract       Date:  2012-09-11

9.  Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations.

Authors:  B Melosky; R Burkes; D Rayson; T Alcindor; N Shear; M Lacouture
Journal:  Curr Oncol       Date:  2009-01       Impact factor: 3.677

10.  Panitumumab-induced acneiform rash in a patient with metastatic colon adenocarcinoma.

Authors:  Paulo Ricardo Saquete Martins-Filho; Simone Yuriko Kameo; Ana Carolina Mascarenhas-Oliveira; Nivaldo Farias Vieira; André Luis de Santana Peixoto
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.